European equities traded in the US as American depositary receipts were moving higher late Friday morning, up 0.48% to 1,412.34 on the S&P Europe Select ADR Index, which is relatively flat for the week.
From continental Europe, the gainers were led by internet browser company Opera (OPRA) and biopharmaceutical company Genfit (GNFT), which rose 6.8% and 2.5%, respectively. They were followed by 3D printer company Materialise (MTLS) and biotech firm BioNTech (BNTX), which were up 2.4% and 1.4%, respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which fell 7.8% and 5.1%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and oil and gas company Eni (E), which were down 1.5% and 1.3%, respectively.
From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo (DEO) and financial services company Barclays (BCS), which increased 2% each. They were followed by financial services company HSBC (HSBC) and cruise line operator Carnival (CUK), which were up 1.5% each.
The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which dropped 4.1% and 3.7%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company TC Biopharm (TCBP), which lost 3.1% and 2.8%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。